ESSA Pharma Inc. — Director's Dealing 2020

Oct 2, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2020-10-01

Reporting Person: Virsik Peter (Chief Operating Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	12570	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options	$4.00	2026-08-09	Common Shares (14500)		Direct
Options	$4.00	2028-02-21	Common Shares (173000)		Direct
Options	$3.81	2029-02-08	Common Shares (40000)		Direct
Options	$3.23	2029-10-07	Common Shares (970000)		Direct